A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.

Senator Doug Mastriano announced he plans to introduce the “Food Purity Protection Act” in Pennsylvania to prevent vaccines from being added to foods. Mastriano (R-Adams and Franklin counties) ...

Google Play is the go-to source for downloading apps on Android. Google ensures that the experience remains safe so that users can trust the apps they download from the platform. However ...

setting the stage for a debut that could make the kidney disease drug developer the first U.S. biotech listing this year. Maze priced the offering at $16 per share, within its indicated range of $ ...

The commission alleged Google unfairly used its dominance to strong-arm device manufacturers and network operators into making sure that traffic on Android devices goes to Google’s own search ...

Longtime political advisers to Vice President JD Vance are joining biotech entrepreneur Vivek Ramaswamy’s expected 2026 campaign for governor of Ohio, The Post has learned. Andy Surabian ...

On Thursday, Jeff Bezos-backed Perplexity launched its AI-powered mobile assistant for Android users. What Happened: Perplexity has introduced its AI-powered mobile assistant on Android ...

The Minister wrote,“As a follow-up to the earlier observation of apparent #DifferentialPricing based on the different models of mobiles (#iPhones/ #Android) being used, Department of Consumer ...

Alongside a slew of announcements tied to Samsung’s Galaxy S25 launch at Samsung Unpacked 2025 on Wednesday, Google announced a pair of accessibility improvements for Android. This includes ...

A requisite majority of H-class shareholders did not approve the buyout, the companies said. "The proposed privatisation of the Company (Henlius) will not proceed and the listing of the H Shares ...

They show that he plans to divest stock holdings, including stakes in biotech firms CRISPR Therapeutics AG and Dragonfly Therapeutics. He’s also stepping down from roles at his law firm and at ...

Primarily, Ascentage hopes to leverage the IPO proceeds to advance its pipeline. Around $50 million to $60 million, for instance, will help the biotech pursue approval for its BCL-2 blocker ...